Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
KPMG Australia’s Leadership Resignations Turn a Whistleblower Case Into a Governance Crisis
Apollo’s Warning on Private Credit Withdrawals Shows the Retail Boom Is Facing Its First Real Stress Test
Claude Innovation Drives Anthropic to $965 Billion Valuation, Edging Out Arch-Rival OpenAI
KPMG Australia’s Leadership Resignations Turn a Whistleblower Case Into a Governance Crisis
Apollo’s Warning on Private Credit Withdrawals Shows the Retail Boom Is Facing Its First Real Stress Test
Claude Innovation Drives Anthropic to $965 Billion Valuation, Edging Out Arch-Rival OpenAI
